What's New
Register by March 2 for the Best Rates
Join us in San Diego from April 30 to May 1, 2020 for the next SMFM Coding Course. Register now and take advantage of our early bird reduced rate.
Read More
Watch Our New Documentary
2020 marks the 40th anniversary of SMFM's Annual Meeting. Learn about the history of the meeting, its growth over the past 40 years, and the amazing involvement of SMFM members in making it the success that it is today.
Read More
Continuing Medicaid for 12 Months Postpartum
SMFM supports federal and state policies that expand Medicaid eligibility and continue Medicaid coverage through 12 months postpartum as a key strategy to address the maternal morbidity and mortality crisis and improve health equity.
Read MoreRecent News
- Leading Experts in Genetics and Pregnancy Announce the Creation of a New Consortium
- Study Confirms Socioeconomic Factors May Not Be the Only Cause of Higher Preterm Birth Rates for Black Women and Women of Mixed Black and White Race
- Study Reveals Virtual Reality Reduces Pain During Childbirth
- New Study Shows Pregnancy-Related Deaths in Hospitals on the Decline, Deaths at Home on the Rise
- Study Indicates All Women Should be Educated After Childbirth About the Signs and Symptoms of High Blood Pressure
- Women with Low Health Literacy More Likely to Encounter Worse Pregnancy Outcomes
- SMFM Launches a New Program Focused on Reproductive Health
Recent Publications
- SMFM Special Statement: The Affordable Care Act's foundation of coverage: essential health benefits are essential
- SMFM Fetal Anomalies Consult Series #2: Extremities
- SMFM Fetal Anomalies Consult Series
- SMFM Fetal Anomalies Consult Series #1: Facial Anomalies
- SMFM Statement: Use of 17-alpha hydroxyprogesterone caproate for prevention of recurrent preterm birth
- Executive summary: Reproductive Services for Women at High Risk for Maternal Mortality Workshop, February 11-12, 2019, Las Vegas, Nevada
- ACOG SMFM OCC #9, Levels of Maternal Care
- SMFM Consult Series #48: Immediate postpartum long-acting reversible contraception for women at high risk for medical complications